277 related articles for article (PubMed ID: 25946121)
1. Immunohistochemical expression of cyclin D1 is higher in supratentorial ependymomas and predicts relapses in gross total resection cases.
de Andrade FG; Marie SK; Uno M; Matushita H; Taricco MA; Teixeira MJ; Rosemberg S; Oba-Shinjo SM
Neuropathology; 2015 Aug; 35(4):312-23. PubMed ID: 25946121
[TBL] [Abstract][Full Text] [Related]
2. RELA Fusion in Supratentorial Extraventricular Ependymomas: A Morphologic, Immunohistochemical, and Molecular Study of 43 Cases.
Wang L; Liu L; Li H; Wang P; Hu Z; Wei Y; Zhang M; Wen W; Li Z; Liu L; Zhao L; Lu D; Teng L
Am J Surg Pathol; 2019 Dec; 43(12):1674-1681. PubMed ID: 31393268
[TBL] [Abstract][Full Text] [Related]
3. Supratentorial extraventricular ependymomas: A retrospective study focused on long-term outcomes and prognostic factors.
Wang M; Zhang R; Liu X; Li D; Qiu C; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
Clin Neurol Neurosurg; 2018 Feb; 165():1-6. PubMed ID: 29253745
[TBL] [Abstract][Full Text] [Related]
4. The role of clinical factors and immunocheckpoint molecules in the prognosis of patients with supratentorial extraventricular ependymoma: a single-center retrospective study.
Wang L; Han S; Yan C; Yang Y; Li Z; Yang Z
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1259-1270. PubMed ID: 33387039
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
Prayson RA
Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
[TBL] [Abstract][Full Text] [Related]
6. Spinal ependymoma in adults: a multicenter investigation of surgical outcome and progression-free survival.
Wostrack M; Ringel F; Eicker SO; Jägersberg M; Schaller K; Kerschbaumer J; Thomé C; Shiban E; Stoffel M; Friedrich B; Kehl V; Vajkoczy P; Meyer B; Onken J
J Neurosurg Spine; 2018 Jun; 28(6):654-662. PubMed ID: 29521579
[TBL] [Abstract][Full Text] [Related]
7. Prognosis by tumor location in adults with intracranial ependymomas.
Sayegh ET; Aranda D; Kim JM; Oh T; Parsa AT; Oh MC
J Clin Neurosci; 2014 Dec; 21(12):2096-101. PubMed ID: 25037313
[TBL] [Abstract][Full Text] [Related]
8. Supratentorial ependymomas: prognostic factors and outcome analysis in a retrospective series of 46 adult patients.
Metellus P; Figarella-Branger D; Guyotat J; Barrie M; Giorgi R; Jouvet A; Chinot O;
Cancer; 2008 Jul; 113(1):175-85. PubMed ID: 18470910
[TBL] [Abstract][Full Text] [Related]
9. Pediatric intracranial ependymomas: prognostic relevance of histological, immunohistochemical, and flow cytometric factors.
Zamecnik J; Snuderl M; Eckschlager T; Chanova M; Hladikova M; Tichy M; Kodet R
Mod Pathol; 2003 Oct; 16(10):980-91. PubMed ID: 14559980
[TBL] [Abstract][Full Text] [Related]
10. Recurrence in supratentorial anaplastic ependymoma.
Kumar R; Singhal N; Jaiswal SK; Mahapatra AK
Pediatr Neurosurg; 2007; 43(5):364-8. PubMed ID: 17786000
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical markers for intracranial ependymoma recurrence. An analysis of 88 cases.
Korshunov A; Golanov A; Timirgaz V
J Neurol Sci; 2000 Aug; 177(1):72-82. PubMed ID: 10967185
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical markers for prognosis of ependymal neoplasms.
Korshunov A; Golanov A; Timirgaz V
J Neurooncol; 2002 Jul; 58(3):255-70. PubMed ID: 12187959
[TBL] [Abstract][Full Text] [Related]
13. Supratentorial hemispheric ependymomas: an analysis of 109 adults for survival and prognostic factors.
Hollon T; Nguyen V; Smith BW; Lewis S; Junck L; Orringer DA
J Neurosurg; 2016 Aug; 125(2):410-8. PubMed ID: 26745489
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in intracranial ependymomas in children.
Figarella-Branger D; Civatte M; Bouvier-Labit C; Gouvernet J; Gambarelli D; Gentet JC; Lena G; Choux M; Pellissier JF
J Neurosurg; 2000 Oct; 93(4):605-13. PubMed ID: 11014538
[TBL] [Abstract][Full Text] [Related]
15. Supratentorial ependymomas in adult patients.
Schwartz TH; Kim S; Glick RS; Bagiella E; Balmaceda C; Fetell MR; Stein BM; Sisti MB; Bruce JN
Neurosurgery; 1999 Apr; 44(4):721-31. PubMed ID: 10201296
[TBL] [Abstract][Full Text] [Related]
16. Supratentorial ependymoma in children: to observe or to treat following gross total resection?
Venkatramani R; Dhall G; Patel M; Grimm J; Hawkins C; McComb G; Krieger M; Wong K; O'Neil S; Finlay JL
Pediatr Blood Cancer; 2012 Mar; 58(3):380-3. PubMed ID: 21370439
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the prognostic significance of selected morphological and immunohistochemical markers in ependymomas, with literature review.
Zawrocki A; Iżycka-Świeszewska E; Papierz W; Liberski PP; Zakrzewski K; Biernat W
Folia Neuropathol; 2011; 49(2):94-102. PubMed ID: 21845537
[TBL] [Abstract][Full Text] [Related]
18. Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial.
Shaw EG; Berkey B; Coons SW; Bullard D; Brachman D; Buckner JC; Stelzer KJ; Barger GR; Brown PD; Gilbert MR; Mehta M
J Neurosurg; 2008 Nov; 109(5):835-41. PubMed ID: 18976072
[TBL] [Abstract][Full Text] [Related]
19. Supratentorial Cortical Ependymomas: A Retrospective Series of 13 Cases at a Single Center.
Wang M; Zhang R; Liu X; Li D; Zhao P; Zuo Y; Zhang P; Wang J; Sun H
World Neurosurg; 2018 Apr; 112():e772-e777. PubMed ID: 29408575
[TBL] [Abstract][Full Text] [Related]
20. Supratentorial extraventricular WHO grade III (anaplastic) ependymoma 17 years after total removal of WHO grade II ependymoma of the fourth ventricle.
Takeda N; Nishihara M; Harada T; Kidoguchi K; Hashimoto K
Br J Neurosurg; 2017 Apr; 31(2):270-272. PubMed ID: 27215793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
